Services | Metronomia - your partner for COVID-19 and other trials during and after the pandemic!

Our recent experiences and successes during the COVID-19 pandemic prove that we are your partners for rapid & high quality support of COVID-19 and other trials.

While carefully managing new and ongoing trials, Metronomia started work on a COVID-19 trial in March 2020, completing the build of essential data management platforms/interfaces and enabling randomization of patients within less than 2 weeks of award.

What is the secret to Metronomia’s success? We know and execute what is needed most now, made possible only by exceptionally committed and high-performing teams that go beyond expectations and industry standards for the feasibility of critically important projects within the shortest timeframes.

Contact us for questions, references or a proposal –

we’re happy to help!


How we can support your COVID-19 or other projects in turbulent times:

  • Biostatistical consulting excellence
    • Time to event data with Competing Risks, e.g. Death or Triage as Competing Event
    • Multistate Modeling, e.g. on / off of ventilation needs
    • Established and proven pathways for ultrashort turnaround times for regulatory authority, ethical-/scientific committee, other vendor/CRO interactions, etc.
    • Our contribution to the fight against COVID-19: Fees from biostatistical consulting for COVID-19 related trials will be donated to the Corona Research Fund of the University Hospital in Essen (spenden-fü (from April to December 2020).
  • Rapid provision of Biostatistics & Data Management essential trial deliverables
    • In-house expertise enabling rapid development of robust statistical sections of study protocol
    • Agile eCRF setup and validation enabling launch within days rather than weeks/months
    • Parallel development of Randomization and IRT for immediate functionality after eCRF launch
  • For the period after Covid-19, robust backend services
    • Biostatistical programming and outputs for short-term reporting and data read-out
    • Medical writing proficiency for your reporting, publishing and other scientific needs
    • Data integration, summaries for filing readiness
    • Remote trial monitoring and decentralized trial approaches
  • Biostatistical services / statistical programming
  • Clinical data management
  • Medical Writing

Essentials for successful COVID-19 studies:

Speed – why is it critical?

  • Because the landscape is extremely competitive and volatile.
  • Because patients and physicians need viable options as soon as possible.

Metronomia is fast because of our dedicated, pragmatic, target-oriented decision makers who are experts in their field.

Agility & Flexibility – why is it critical?

  • Because the situation is new and dynamic, with insights developing daily
  • Because conditions (e.g. in ICUs, hospitals, regions, standard of care, etc.) vary and “one size fits all” approaches may not be possible.
  • Because customization as trials progress is advantageous due to rapid setup, and real-time learnings and optimization.

At Metronomia our processes work for our projects and not against them!

Expertise in Data Science – why is it critical?

  • To fill gaps in knowledge & understanding
  • To propose highly effective & qualitative solutions, both conventional & non-conventional
  • To get the job done successfully and efficiently
  • To support approval of safe and efficacious drugs and dropping of those that are not

Metronomia – 30 years of experience, 85% return business, 90% referrals, 100% know-how

Cost Effectiveness & Efficiency – why is it critical?

  • Responsible budgeting and spend are key to good partnerships
  • Value for money means less money spent now and more for future endeavors
  • Well established processes save time, money and resource for all parties involved

At Metronomia, you pay for professional services, not for professional marketing!


Case-Study: COVID-19 Case Study @Metronomia

  • COVID-19 trial in ICU patients initiated end of March 2020
  • Achievements in the COVID-19 trial setup
    • Development of a phase II/III statistical design within 3 days
    • Development of a fully functional eCRF from receipt of draft protocol to eCRF go-live within 5 days
    • Setup of randomization and provision of a fully integrated IRT technology that allowed First Patient Randomized within 2 hours of eCRF go-live.
  • Metronomia’s contributions to this COVID-19 trial
    • Statistical consulting and study protocol development
    • Clinical data management, provision of eCRF and IRT
    • Randomization
    • Statistical programming
    • Reporting

Why Metronomia is your partner for COVID-19 and other trials

  • Relevant Experience:
    • Our COVID-19 trial team is familiar with associated challenges and ready to serve new partners
    • Proven track record of rapid trial setup and timely, successful execution of services
    • Over 30 relevant studies in past 5 years in vaccine, immunology, respiratory diseases and other related areas
    • Experts in critical care indication trials
    • 30 successful years of DataScience@Metronomia due to exceptional reliability, quality and customer experience
  • Operational Excellence:
    • Exceptional quality and performance
    • Passion & commitment for “better data”
    • Unrivalled flexibility and agility
    • Customized service through dedicated project teams
    • Well-established processes, pathways and state-of-the-art technology

Let us support you in your effort to combat COVID-19 and/or other conditions in the challenging period ahead. Our specialists are available anytime for a consultation. Contact us and we will be happy to get in touch with you!

Corona-related news


We’ll donate all revenues from statistical consulting for COVID-19 studies.


Metronomia successfully implemented an accelerated setup for a first clinical study in COVID-19 patients.


Metronomia is prepared. Effective measures have been implemented ...